Apex Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 21-12-2024
- Paid Up Capital ₹ 0.10 M
as on 21-12-2024
- Company Age 23 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 73.85%
(FY 2022)
- Profit 38.39%
(FY 2022)
- Ebitda 23.82%
(FY 2022)
- Net Worth 34.83%
(FY 2022)
- Total Assets 59.72%
(FY 2022)
About Apex Pharmachem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ashwinkumar Patel and Vijay Sonawane serve as directors at the Company.
- CIN/LLPIN
U24231GJ2001PTC039424
- Company No.
039424
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Apr 2001
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Valsad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Apex Pharmachem?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Sonawane  | Director | 17-May-2021 | Current |
| Ashwinkumar Patel | Director | 01-Nov-2013 | Current |
Financial Performance of Apex Pharmachem.
Apex Pharmachem Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 73.85% increase. The company also saw a substantial improvement in profitability, with a 38.39% increase in profit. The company's net worth Soared by an impressive increase of 34.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apex Pharmachem?
In 2022, Apex Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Apex Pharmachem?
Apex Pharmachem has a workforce of 79 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apex Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apex Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
